265 related articles for article (PubMed ID: 17507431)
1. MMPs contribute to TNF-alpha-induced alteration of the blood-cerebrospinal fluid barrier in vitro.
Zeni P; Doepker E; Schulze-Topphoff U; Huewel S; Tenenbaum T; Galla HJ
Am J Physiol Cell Physiol; 2007 Sep; 293(3):C855-64. PubMed ID: 17507431
[TBL] [Abstract][Full Text] [Related]
2. Phorbol ester induced short- and long-term permeabilization of the blood-CSF barrier in vitro.
Angelow S; Zeni P; Höhn B; Galla HJ
Brain Res; 2005 Nov; 1063(2):168-79. PubMed ID: 16271356
[TBL] [Abstract][Full Text] [Related]
3. Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines.
Krizanac-Bengez L; Hossain M; Fazio V; Mayberg M; Janigro D
Am J Physiol Cell Physiol; 2006 Oct; 291(4):C740-9. PubMed ID: 16707552
[TBL] [Abstract][Full Text] [Related]
4. MMPs/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders.
Xing Y; Shepherd N; Lan J; Li W; Rane S; Gupta SK; Zhang S; Dong J; Yu Q
Brain Behav Immun; 2017 Oct; 65():161-172. PubMed ID: 28487203
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes.
Muir EM; Adcock KH; Morgenstern DA; Clayton R; von Stillfried N; Rhodes K; Ellis C; Fawcett JW; Rogers JH
Brain Res Mol Brain Res; 2002 Apr; 100(1-2):103-17. PubMed ID: 12008026
[TBL] [Abstract][Full Text] [Related]
6. Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases.
Brkic M; Balusu S; Van Wonterghem E; Gorlé N; Benilova I; Kremer A; Van Hove I; Moons L; De Strooper B; Kanazir S; Libert C; Vandenbroucke RE
J Neurosci; 2015 Sep; 35(37):12766-78. PubMed ID: 26377465
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.
Knittel T; Mehde M; Grundmann A; Saile B; Scharf JG; Ramadori G
Histochem Cell Biol; 2000 Jun; 113(6):443-53. PubMed ID: 10933221
[TBL] [Abstract][Full Text] [Related]
8. TNFalpha induces choroid plexus epithelial cell barrier alterations by apoptotic and nonapoptotic mechanisms.
Schwerk C; Rybarczyk K; Essmann F; Seibt A; Mölleken ML; Zeni P; Schroten H; Tenenbaum T
J Biomed Biotechnol; 2010; 2010():307231. PubMed ID: 20369072
[TBL] [Abstract][Full Text] [Related]
9. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone prevents alteration of tight junction-associated proteins and barrier function in porcine choroid plexus epithelial cells after infection with Streptococcus suis in vitro.
Tenenbaum T; Matalon D; Adam R; Seibt A; Wewer C; Schwerk C; Galla HJ; Schroten H
Brain Res; 2008 Sep; 1229():1-17. PubMed ID: 18644352
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes.
Agapova OA; Ricard CS; Salvador-Silva M; Hernandez MR
Glia; 2001 Mar; 33(3):205-16. PubMed ID: 11241738
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase expression and activity following prostaglandin F(2 alpha)-induced luteolysis.
Ricke WA; Smith GW; Smith MF
Biol Reprod; 2002 Mar; 66(3):685-91. PubMed ID: 11870075
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke.
Kouwenhoven M; Carlström C; Ozenci V; Link H
J Clin Immunol; 2001 Sep; 21(5):365-75. PubMed ID: 11720009
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
16. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
17. Involvement of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the chicken oviduct regression and recrudescence.
Leśniak-Walentyn A; Hrabia A
Cell Tissue Res; 2016 Nov; 366(2):443-454. PubMed ID: 27342592
[TBL] [Abstract][Full Text] [Related]
18. Differential expression profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases in females with or without pelvic organ prolapse.
Wang X; Li Y; Chen J; Guo X; Guan H; Li C
Mol Med Rep; 2014 Oct; 10(4):2004-8. PubMed ID: 25110112
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
20. Regression of left ventricular hypertrophy after surgical therapy for aortic stenosis is associated with changes in extracellular matrix gene expression.
Walther T; Schubert A; Falk V; Binner C; Kanev A; Bleiziffer S; Walther C; Doll N; Autschbach R; Mohr FW
Circulation; 2001 Sep; 104(12 Suppl 1):I54-8. PubMed ID: 11568030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
